8-39610632-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014237.3(ADAM18):c.448G>A(p.Val150Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,612,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014237.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAM18 | NM_014237.3 | c.448G>A | p.Val150Ile | missense_variant | 6/20 | ENST00000265707.10 | NP_055052.1 | |
ADAM18 | NM_001320313.2 | c.448G>A | p.Val150Ile | missense_variant | 6/19 | NP_001307242.1 | ||
ADAM18 | NM_001190956.2 | c.448G>A | p.Val150Ile | missense_variant | 6/6 | NP_001177885.1 | ||
ADAM18 | NR_135201.2 | n.399+1071G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAM18 | ENST00000265707.10 | c.448G>A | p.Val150Ile | missense_variant | 6/20 | 1 | NM_014237.3 | ENSP00000265707 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152024Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250020Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135170
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460828Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 726750
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74378
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at